Skip to content
Application 065415
- Type
- ANDA
- Sponsor
- ACS DOBFAR
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | CEFOXITIN | CEFOXITIN SODIUM | INJECTABLE;INJECTION | EQ 10GM BASE/VIAL | No | Yes |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 25021-111 | Cefoxitin | cefoxitin | Sagent Pharmaceuticals | ANDA | Current |
| 25021-111 | Cefoxitin | cefoxitin | Sagent Pharmaceuticals | ANDA | Current |
| 44567-247 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-247 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 44567-247 | Cefoxitin | Cefoxitin | WG Critical Care, LLC | ANDA | Current |
| 63323-343 | Cefoxitin | Cefoxitin | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-343 | Cefoxitin | Cefoxitin | Fresenius Kabi USA, LLC | ANDA | Current |